Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
ArQule |
---|---|
Information provided by: | ArQule |
ClinicalTrials.gov Identifier: | NCT00310518 |
The purpose of this study is to assess the overall response rate (ORR) of persistent, recurrent or metastatic leiomyosarcoma in patients treated with ARQ 501.
Condition | Intervention | Phase |
---|---|---|
Cancer |
Drug: ARQ 501 |
Phase II |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase 2 Multi Center Open Label Study of ARQ 501 in Adult Patients With Recurrent, Persistent or Metastatic Leiomyosarcoma |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Arizona | |
Premiere Oncology of Arizona | |
Scottsdale, Arizona, United States, 85260 | |
United States, California | |
Premiere Oncology | |
Santa Monica, California, United States, 90404 | |
City of Hope Medical Center | |
Duarte, California, United States, 91010 | |
United States, New York | |
Memorial Sloan-Kettering Cancer Center | |
New York, New York, United States, 10021 | |
United States, Pennsylvania | |
Pennsylvania Oncology Hematology Associates | |
Philadelphia, Pennsylvania, United States, 19106 |
Study ID Numbers: | ARQ 501-221 |
Study First Received: | March 31, 2006 |
Last Updated: | April 28, 2009 |
ClinicalTrials.gov Identifier: | NCT00310518 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Neoplasms, Connective and Soft Tissue Soft Tissue Sarcomas Malignant Mesenchymal Tumor Anti-Retroviral Agents Radiation-Sensitizing Agents Beta-lapachone |
Leiomyosarcoma Sarcoma Antiviral Agents Recurrence Reverse Transcriptase Inhibitors |
Neoplasms, Muscle Tissue Anti-Infective Agents Neoplasms by Histologic Type Molecular Mechanisms of Pharmacological Action Leiomyosarcoma Physiological Effects of Drugs Enzyme Inhibitors Antiviral Agents Pharmacologic Actions |
Reverse Transcriptase Inhibitors Neoplasms, Connective and Soft Tissue Neoplasms Anti-Retroviral Agents Beta-lapachone Radiation-Sensitizing Agents Therapeutic Uses Sarcoma Nucleic Acid Synthesis Inhibitors |